• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    MediWound Ltd. - Ordinary Shares (NQ:MDWD)

    18.19 +0.11 (+0.61%)
    Streaming Delayed Price Updated: 2:32 PM EDT, Apr 28, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 22,220
    Open 18.18
    Bid (Size) 18.06 (2)
    Ask (Size) 18.32 (2)
    Prev. Close 18.08
    Today's Range 18.08 - 18.40
    52wk Range 12.78 - 24.00
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    MediWound to Present New EscharEx® Data at Leading Wound Care Conferences
    From MediWound Ltd.
    Via GlobeNewswire
    MediWound Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
    From MediWound Ltd.
    Via GlobeNewswire

    Performance

    YTD
    +1.1%
    +1.1%
    1 Month
    +14.0%
    +14.0%
    3 Month
    -10.1%
    -10.1%
    6 Month
    +3.5%
    +3.5%
    1 Year
    -5.4%
    -5.4%

    More News

    Read More
    Earnings Scheduled For March 19, 2025
    Via Benzinga
    Earnings Preview: MediWound
    Via Benzinga
    MediWound to Report Fourth Quarter and Full Year 2024 Financial Results
    From MediWound Ltd.
    Via GlobeNewswire
    This CoStar Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
    Via Benzinga
    MediWound Announces Phase III CIDS Publication on NexoBrid® for Pediatric Burn Care
    From MediWound Ltd.
    Via GlobeNewswire
    MediWound to Present at the 45th Annual TD Cowen Health Care Conference
    From MediWound Ltd.
    Via GlobeNewswire
    MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers
    From MediWound Ltd.
    Via GlobeNewswire
    MediWound to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
    From MediWound Ltd.
    Via GlobeNewswire
    MediWound to Host Virtual Key Opinion Leader Event to Discuss EscharEx® Phase III VALUE Study in Venous Leg Ulcers and Its Commercial Opportunity on January 8, 2025
    From MediWound Ltd.
    Via GlobeNewswire
    Urban Outfitters To Rally Around 47%? Here Are 10 Top Analyst Forecasts For Wednesday
    Via Benzinga
    MediWound Reports Third Quarter 2024 Financial Results and Provides Company Update
    From MediWound Ltd.
    Via GlobeNewswire
    Earnings Scheduled For November 26, 2024
    Via Benzinga
    MediWound to Report Third Quarter 2024 Financial Results
    From MediWound Ltd.
    Via GlobeNewswire
    MediWound Announces Phase II Head-to-Head Study Evaluating EscharEx® vs. Collagenase in Patients with Venous Leg Ulcers
    From MediWound Ltd.
    Via GlobeNewswire
    MediWound to Participate in the 2024 Maxim Healthcare Virtual Summit
    From MediWound Ltd.
    Via GlobeNewswire
    MediWound to Present at the H.C. Wainwright 26th Annual Global Investment Conference
    From MediWound Ltd.
    Via GlobeNewswire
    MediWound Announces U.S. Food and Drug Administration Approval of NexoBrid® for the Treatment of Pediatric Patients with Severe Thermal Burns
    From MediWound Ltd.
    Via GlobeNewswire
    MDWD Stock Earnings: MediWound Misses EPS, Beats Revenue for Q2 2024
    Via InvestorPlace
    MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update
    From MediWound Ltd.
    Via GlobeNewswire
    MediWound Announces Positive Results from the U.S. NexoBrid® Expanded Access Protocol (NEXT)
    From MediWound Ltd.
    Via GlobeNewswire
    MediWound to Report Second Quarter 2024 Financial Results
    From MediWound Ltd.
    Via GlobeNewswire
    MediWound Announces Publication of the EscharEx® Phase II ChronEx Study Results for Venous Leg Ulcers
    From MediWound Ltd.
    Via GlobeNewswire
    MediWound Announces €16.25 Million Funding from the European Innovation Council Accelerator Program
    From MediWound Ltd.
    Via GlobeNewswire

    Frequently Asked Questions

    Is MediWound Ltd. - Ordinary Shares publicly traded?
    Yes, MediWound Ltd. - Ordinary Shares is publicly traded.
    What exchange does MediWound Ltd. - Ordinary Shares trade on?
    MediWound Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for MediWound Ltd. - Ordinary Shares?
    The ticker symbol for MediWound Ltd. - Ordinary Shares is MDWD on the Nasdaq Stock Market
    What is the current price of MediWound Ltd. - Ordinary Shares?
    The current price of MediWound Ltd. - Ordinary Shares is 18.19
    When was MediWound Ltd. - Ordinary Shares last traded?
    The last trade of MediWound Ltd. - Ordinary Shares was at 04/28/25 02:32 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.